178
Participants
Start Date
September 4, 2018
Primary Completion Date
September 30, 2020
Study Completion Date
December 31, 2021
Onivyde
The recommended dose and regimen of Onivyde is 70 mg/m2 intravenously over 90 minutes, followed by dl-LV 400mg/m2 or l-LV 200mg/m2 intravenously over 30 minutes, followed by 5-FU 2400 mg/m2 intravenously over 46 hours, administered every 2 weeks.
5-FU/LV
The recommended dose and regimen of dl-LV 400mg/m2 or l-LV 200mg/m2 intravenously over 30 minutes, followed by 5-FU 2400 mg/m2 intravenously over 46 hours, administered every 2 weeks
Asan Medical Center, Seoul
Ulsan University Hospital
OTHER
Chungnam National University Hospital
OTHER
Kyungpook National University Chilgok Hospital
OTHER
Inje University
OTHER
Changhoon Yoo
OTHER